Terrie Curran's Net Worth
Terrie Curran's net worth is estimated to be at least $2,944,747.10 as of 02/23/2025. CoreStreet's estimation of Terrie Curran's net worth is based on their sale of stock and current holding of stock.
Terrie Curran is Insider at Phathom Pharmaceuticals Inc. They have executed at least 11 trades of stock as per SEC Form 4 filings. Their most recent trade was for 19,109 units of PHAT stock on 01/21/2025. Their biggest sale was on 09/18/2019 when they sold 11,338 units of Bristol-Myers Squibb Company stock for $1,114,185.26. They typically trade 1 times per year.
Total value of insider buys:
- $252,931.58
Total value of insider sells:
- $2,691,815.52
Most recent insider trade:
- Jan. 21, 2025
Terrie Curran's Insider Trading History
| Phathom Pharmaceuticals Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Jan. 21, 2025 | Insider | 19,109 | $6.59 | Sell | $125,928.31 |
July 15, 2024 | Insider | 33,848 | $11.72 | Sell | $396,698.56 |
March 22, 2024 | Insider | 16,851 | $9.11 | Sell | $153,512.61 |
April 6, 2023 | Insider | 12,919 | $7.82 | Buy | $101,026.58 |
March 1, 2023 | Insider | 1,436 | $8.54 | Sell | $12,263.44 |
Jan. 20, 2023 | Insider | 5,821 | $8.20 | Sell | $47,732.20 |
May 13, 2022 | Insider | 20,500 | $7.41 | Buy | $151,905.00 |
March 22, 2021 | Insider | 11,513 | $43.32 | Sell | $498,743.16 |
| Arcutis Biotherapeutics Inc | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Nov. 11, 2024 | Director | 8,687 | $10.85 | Sell | $94,253.95 |
| Bristol-Myers Squibb Company | Title | Amount | Price | Type | Total Value |
|---|---|---|---|---|---|
Sept. 18, 2019 | Insider | 11,338 | $98.27 | Sell | $1,114,185.26 |
Sept. 25, 2017 | Insider | 1,727 | $143.89 | Sell | $248,498.03 |